Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00106431
Status:
COMPLETED
Last Update Posted:
2019-10-30
First Post:
2005-03-24
Brief Title:
A Single Agent Phase II Study of Romidepsin Depsipeptide FK228 in the Treatment of Cutaneous T-cell Lymphoma CTCL
Sponsor:
Celgene
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
GPI-04-0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |